Psychedelics can change humanity for the better. It ’s time to unlock their power | Rick Doblin

Studies of MDMA, ketamine, psilocybin mushrooms and other psychedelics have shown tremendous potential for therapeutic applicationsI study psychedelics. The organization I work for – theMultidisciplinary Association for Psychedelic Studies (MAPS) – has been researching MDMA since 1992, seven years after the substance was prohibited. Our organization was founded in 1985.One of a few treatments designated a breakthrough therapy by the FDA, MDMA-assisted therapy for post-traumatic stress disorder is an incredibly promising treatment for this devastating mental injury. Survivors of PTSD may struggle to stay connected in their work, families, and communities. They often live with symptoms like insomnia, hyper-vigilance and isolation; these commonly lead to substance use disorder, depression, chronic pain or heart problems. Yet most of the available treatments provide symptom relief for only about half of the people with the diagnosis, with even fewer people experiencing remission.Rick Doblin, PhD, is the founder and executive director of theMultidisciplinary Association for Psychedelic Studies and a member of the Board of Directors of its wholly owned drug development subsidiary,MAPS Public Benefit CorporationContinue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Fungi Biology Science Medicine Source Type: news